HUTCHMED (China) (HCM) Ratios
9 Followers
HUTCHMED (China) Ratios
GB:HCM's free cash flow for Q2 2026 was $3.30M. For the 2026 fiscal year, GB:HCM's free cash flow was decreased by $-2.81M and operating cash flow was $6.11M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.96 | 2.83 | 2.72 | 2.37 | 3.89 |
| Quick Ratio | 4.83 | 2.70 | 2.60 | 2.21 | 3.77 |
| Cash Ratio | 0.23 | 0.41 | 0.70 | 0.89 | 1.21 |
| Solvency Ratio | 0.94 | 0.10 | 0.20 | -0.90 | -0.56 |
| Operating Cash Flow Ratio | -0.21 | 0.00 | 0.54 | -0.76 | -0.66 |
| Short-Term Operating Cash Flow Coverage | -2.59 | 0.02 | 7.04 | 0.00 | -7.59 |
| Net Current Asset Value | $ 1.07B | $ 564.21M | $ 560.45M | $ 447.31M | $ 878.93M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.07 | 0.07 | 0.03 | 0.03 |
| Debt-to-Equity Ratio | 0.08 | 0.12 | 0.12 | 0.04 | 0.04 |
| Debt-to-Capital Ratio | 0.07 | 0.11 | 0.11 | 0.04 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.07 | 0.06 | 0.03 | 0.00 |
| Financial Leverage Ratio | 1.42 | 1.68 | 1.75 | 1.69 | 1.39 |
| Debt Service Coverage Ratio | -3.21 | 0.26 | 1.97 | -614.76 | -12.11 |
| Interest Coverage Ratio | -13.67 | -14.14 | 24.21 | -625.30 | -554.59 |
| Debt to Market Cap | 0.04 | 0.03 | 0.03 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.12 | 0.11 | 0.10 | 0.03 | 0.05 |
| Net Debt to EBITDA | -1.03 | -4.55 | -2.94 | 0.71 | 1.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 11.64% | 44.64% | 18.08% | 27.04% | 27.49% |
| EBIT Margin | -7.14% | 0.28% | 7.05% | -96.10% | -92.19% |
| EBITDA Margin | -4.71% | 2.24% | 8.03% | -94.07% | -90.17% |
| Operating Profit Margin | -7.14% | -6.44% | 2.19% | -95.61% | -92.19% |
| Pretax Profit Margin | 95.05% | 7.20% | 12.60% | -84.58% | -43.56% |
| Net Profit Margin | 83.30% | 5.99% | 12.03% | -84.62% | -54.66% |
| Continuous Operations Profit Margin | 83.45% | 6.06% | 12.06% | -84.52% | -46.90% |
| Net Income Per EBT | 87.64% | 83.17% | 95.43% | 100.05% | 125.48% |
| EBT Per EBIT | -1331.31% | -111.70% | 574.71% | 88.47% | 47.25% |
| Return on Assets (ROA) | 26.07% | 2.96% | 7.87% | -35.05% | -14.18% |
| Return on Equity (ROE) | 36.91% | 4.96% | 13.80% | -59.12% | -19.72% |
| Return on Capital Employed (ROCE) | -2.72% | -4.52% | 2.10% | -60.35% | -30.94% |
| Return on Invested Capital (ROIC) | -2.35% | -3.70% | 1.93% | -59.97% | -30.04% |
| Return on Tangible Assets | 26.25% | 2.96% | 14.89% | -35.05% | -14.22% |
| Earnings Yield | 19.76% | 1.51% | 3.30% | -13.86% | -3.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.71 | 3.76 | 7.17 | 4.35 | 4.26 |
| Payables Turnover | 10.65 | 8.20 | 18.90 | 4.37 | 6.27 |
| Inventory Turnover | 11.79 | 6.92 | 13.66 | 5.49 | 7.22 |
| Fixed Asset Turnover | 5.62 | 6.50 | 8.03 | 5.04 | 5.37 |
| Asset Turnover | 0.31 | 0.49 | 0.65 | 0.41 | 0.26 |
| Working Capital Turnover Ratio | 0.57 | 0.91 | 1.42 | 0.62 | 0.56 |
| Cash Conversion Cycle | 95.04 | 105.40 | 58.32 | 66.95 | 78.00 |
| Days of Sales Outstanding | 98.36 | 97.15 | 50.91 | 83.88 | 85.66 |
| Days of Inventory Outstanding | 30.97 | 52.73 | 26.72 | 66.51 | 50.54 |
| Days of Payables Outstanding | 34.29 | 44.49 | 19.32 | 83.44 | 58.20 |
| Operating Cycle | 129.33 | 149.88 | 77.64 | 150.39 | 136.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.07 | 0.00 | 0.26 | -0.32 | -0.26 |
| Free Cash Flow Per Share | -0.09 | -0.02 | 0.22 | -0.36 | -0.28 |
| Dividend Paid and CapEx Coverage Ratio | -4.57 | 0.03 | 6.72 | -7.33 | -12.19 |
| Capital Expenditure Coverage Ratio | -4.57 | 0.03 | 6.72 | -7.33 | -12.19 |
| Operating Cash Flow Coverage Ratio | -0.66 | 0.01 | 2.55 | -9.95 | -5.24 |
| Operating Cash Flow to Sales Ratio | -0.12 | 0.00 | 0.26 | -0.63 | -0.57 |
| Free Cash Flow Yield | -3.41% | -0.70% | 6.12% | -11.73% | -3.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 5.09 | 66.15 | 30.27 | -7.21 | -29.48 |
| Price-to-Sales (P/S) Ratio | 4.22 | 3.96 | 3.64 | 6.10 | 16.11 |
| Price-to-Book (P/B) Ratio | 1.87 | 3.28 | 4.18 | 4.26 | 5.81 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -29.30 | -143.13 | 16.34 | -8.53 | -25.97 |
| Price-to-Operating Cash Flow Ratio | -35.71 | 5021.30 | 13.91 | -9.69 | -28.10 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -1.04 | -0.24 | -0.10 | -0.76 |
| Enterprise Value Multiple | -90.47 | 172.37 | 42.41 | -5.77 | -16.81 |
| Enterprise Value | 2.34B | 2.43B | 2.85B | 2.32B | 5.40B |
| EV to EBITDA | -90.47 | 172.37 | 42.41 | -5.77 | -16.81 |
| EV to Sales | 4.26 | 3.86 | 3.40 | 5.43 | 15.16 |
| EV to Free Cash Flow | -29.63 | -139.45 | 15.29 | -7.59 | -24.43 |
| EV to Operating Cash Flow | -36.12 | 4892.25 | 13.01 | -8.62 | -26.44 |
| Tangible Book Value Per Share | 1.42 | 0.70 | 0.74 | 0.75 | 1.31 |
| Shareholders’ Equity Per Share | 1.42 | 0.88 | 0.86 | 0.72 | 1.25 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.12 | 0.16 | 0.04 | 0.00 | -0.08 |
| Revenue Per Share | 0.63 | 0.73 | 0.99 | 0.50 | 0.45 |
| Net Income Per Share | 0.52 | 0.04 | 0.12 | -0.43 | -0.25 |
| Tax Burden | 0.88 | 0.83 | 0.95 | 1.00 | 1.25 |
| Interest Burden | -13.31 | 25.70 | 1.79 | 0.88 | 0.47 |
| Research & Development to Revenue | 0.28 | 0.34 | 0.36 | 0.63 | 0.58 |
| SG&A to Revenue | 0.19 | 0.18 | 0.10 | 0.22 | 0.25 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.04 | 0.07 | 0.12 |
| Income Quality | -0.14 | 0.01 | 2.17 | 0.75 | 1.22 |
Currency in USD
